David Zhang graduated in Computer Science from Peking University. He received his MSc in 1982 and his PhD in 1985 in both Computer Science from the Harbin Institute of Technology (HIT), respectively. From 1986 to 1988 he was a Postdoctoral Fellow at Tsinghua University and then an Associate Professor at the Academia Sinica, Beijing. In 1994 he received his second PhD in Electrical and Computer Engineering from the University of Waterloo, Ontario, Canada. He has been a Chair Professor at the Hong Kong Polytechnic University where he is the Founding Director of Biometrics Research Centre (UGC/CRC) supported by the Hong Kong SAR Government since 2005. Currently, he is Presidential Chair Professor in Chinese University of Hong Kong (Shenzhen). He also serves as Visiting Chair Professor in Tsinghua University and HIT, and Adjunct Professor in Shanghai Jiao Tong University, Peking University, National University of Defense Technology and the University of Waterloo. He is the Founder and Editor-in-Chief, International Journal of Image and Graphics (IJIG); Book Editor, Springer International Series on Biometrics (KISB); Organizer, the first International Conference on Biometrics Authentication (ICBA); Associate Editor of more than ten international journals including IEEE Transactions and so on. Over past 30 years, he have been working on pattern recognition, image processing and biometrics, where many research results have been awarded and some created directions, including palmprint recognition, computerized TCM and facial beauty analysis, are famous in the world. So far, he has published over 20 monographs, 400 international journal papers and 40 patents from USA/Japan/HK/China. He has been continuously listed as a Highly Cited Researchers in Engineering by Clarivate Analytics (formerly known as Thomson Reuters) in 2014, 2015, 2016, 2017, 2018 and 2019, respectively (http://highlycited.com). He is also ranked 80 with H-Index 115 at Top 1000 Scientists for international Computer Science and Electronics (http://www.guide2research.com/scientists). Professor Zhang is a Croucher Senior Research Fellow, Distinguished Speaker of the IEEE Computer Society, and an IEEE Life Fellow and IAPR Fellow.

Henryk Kalisz obtained his BSc (Hons) in Biological Sciences in 1981 and PhD in Biochemistry in 1985 at the University of Manchester. He then worked as a postdoctorate at the University of Freiburg, Germany, in the group of Prof. Helmut Holzer In 1987. He joined the National Research Institute (Gesellschaft für Biotechnologische Forschung) in Braunschweig, Germany, as Senior Scientist and Project Leader, leading a number of projects, including structure-function studies of Technical Enzymes, Trypanosomal Peroxidase System, Tyrosine Aminotransferases. In 1996 he also took up a Lectureship position at the Magdeburg Fachhochschule, Germany, lecturing final year Chemistry Diploma students on Biochemistry. In September 2001 he joined Pharmacia (Pharmacia-Pfizer and Nerviano Medical Sciences), Nerviano, Italy, as Head of Biochemistry, where he was responsible for the design, production and characterisation of proteins for structure-based drug design and for the identification of biomarkers for clinical studies. In 2007 he joined Eucodis Bioscience in Vienna, Austriaas Chief Scientific Officer and in October 2011 he formed Enzymes4Biotech in Pinner, UK, applying his expertise in industrial enzymology as a consultant and independent representative to provide scientific and technological advice and assistance to Biotechnology and Pharmaceuticals organizations. He is currently focusing is on the discovery, design and development of customised enzymes for various industrial applications, as well as the application of biocatalytic processes for the development of bio-based productsand for the (chemo-) enzymatic synthesis of pharmaceutical intermediates and APIs.He has published over 60 international scientific publications, as well as patents and book chapters.

Dr. Joseph Curtis is the Founder and Chief Scientific Officer of BioQuant Labs and works with entrepreneurial firms developing biomedical systems to participate in the digital health revolution. Participating in IBM’s Global Entrepreneur program, Curtis was successful in integrating an intelligent genomic diagnostic platform incorporating big data analytics, cloud storage and cognitive computing capability, this was one of IBMs initial forays into evaluating the potential of digital health platforms. Later, the Economist Magazine recognized Curtis and invited him to contribute to their discussions on the future of genomic medicine. As a biomedical technology management executive, Curtis completed the Siemens Diagnostics Executive Management Program and served on NIST’s Board of Examiners for Performance Excellence. He is also a Lean six-sigma Champion and his teams have realized over $30 million in cost savings for a nation-wide supplier of cellular therapies and diagnostic reagents generating $2 billion annually. During Joseph’s twenty-five-year career he has held several executive positions in government, non-profit and entrepreneurial firms. He has provided program management support for over $300 million in investments into technological innovations across the biomedical technology innovation ecosystem. This includes: regenerative medicine, manufacturing blood plasma derivatives and cellular therapies for tissue engineering, integrating digital diagnostic imaging systems for combat casualty care, introducing medical lasers for vision correction into the U.S. marketplace, and developing molecular diagnostics to identify blood-borne pathogens, select agents and emerging infectious diseases. As a biomedical systems engineer, Curtis assisted medical devices manufacturers to obtain market clearance for their products in the U.S., Canada and Japan. Curtis received his Ph.D. in Cell & Developmental Biology, from the University of California, Davis and conducted post-doctoral research at the National Cancer Institute.

Dr. Brian Tobin, is the CEO and Principal of "Tobin Biomedical Consultants, LLC", Executive Director and Founder of "Synergy Global Health Foundation, Inc." He has 25 years of AAMC Medical School administrative, research, clinical, and educational experience as Professor of Biomedical Science, Pediatrics and Internal Medicine. Dr. Tobin was the Founding Chair, Department of Biomedical Sciences at UofSC Medical School, Greenville SC. and served as Associate Dean for Medical Education and Founding Chair Dept of Medical Education at The Paul L. Foster School of Medicine, El Paso TX. Dr. Tobin and colleagues have founded three "New Generation" AAMC medical schools, including Mercer University School of Medicine, Savannah GA. During his 25-year career, Dr. Tobin has engaged basic medical science educators, biomedical scientists, clinicians, and allied healthcare professionals in research and patient practice where he developed interdisciplinary and interprofessional medical programs. His research in diabetes, nutrition, exercise, islet transplantation, and microgravity was funded by the NIH, NASA, ASEE, NSBRI, IBMP, and Philanthropic Research Foundations. In 2000, he served on the Executive Committee, NHLBI Nutrition Academic Award, as Editor of the NIH "Nutrition Curriculum Guide for Training Physicians." In 2003, he received the Grace Goldsmith Award from the American College of Nutrition and the Outstanding Nutrition Alumni Award from the PSU Nutrition and Dietetics Alumni Society. In 2007, he was bestowed the Presidential Award by the American College of Nutrition. Dr. Tobin presided over numerous national and international symposia for prestigious scientific societies. In 1995, he served on the Board of Directors, PSU Alumni Society, Health & Human Development, and was President 2005–2006. In 2006-2007 he served as President of the American College of Nutrition. In 2012, he was elected Scientific Councilor to the Medical Nutrition Council of the American Society for Nutrition. The following are the Professional Society memberships of Dr. Tobin : American College of Nutrition (ACN), American College of Sports Medicine (ACSM), American Diabetes Association (ADA), American Society for Nutrition (ASN), American Society for Nutritional Sciences (ASNS), American Society for Clinical Nutrition (ASCN), Canadian Diabetes Association (CDA), International Association for Medical Science Education (IAMSE), International Pancreatic Islet Transplant Association (IPITA).

Ge Wang is Clark & Crossan Endowed Chair Professor and Director of Biomedical Imaging Center, Rensselaer Polytechnic Institute, Troy, NY, USA. He published the first spiral cone-beam CT paper in 1990s and since then many papers systematically contributed to theory, algorithms, artifact reduction and biomedical applications in this important area. Currently, there are ~200 million medical CT scans yearly with a majority in the spiral/helical cone-beam/multi-slice mode. His group and collaborators developed interior tomography to solve the long-standing “interior problem” for high-fidelity local reconstruction, and proposed omni-tomography (“all-in-one” and “all-at-once”) with CT-MRI as an example. He initiated bioluminescence tomography as a new molecular imaging modality. He wrote the first perspective on deep-learning-based tomographic imaging in 2016 as the new frontier of machine learning, 2 papers on deep imaging in Nature Machine Intelligence, and a textbook on this topic with his coauthors published by IOP in 2019. He wrote over 500 journal papers and 100 issued and pending patents, receiving a high number of citations and academic recognitions/awards. His results were featured in Nature, Science, PNAS, and news media. His team has been continuously and strongly funded by federal agencies and companies. His main interest is in medical imaging and artificial intelligence. He is Outstanding Associate Editor of IEEE Transactions on Medical Imaging and Lead Guest Editor of 6 special issues for this flagship journal. He is Fellow of IEEE, SPIE, OSA, AIMBE, AAPM, AAAS, and National Academy of Inventors.

Dr. Temple Smith obtained his PhD in Nuclear Physics from the University of Colorado in 1969, followed byan NIH (USA) postdoctoral fellowship under the direction of the mathematician, Stanislaw Ulam, and the molecular biologist, John R. Sadler. Dr. Smith is one of the founders of GenBank, initially at Los Alamos National Laboratory, and the co-developer, with Michael Waterman, of the Smith-Waterman sequence alignment algorithm. Beginning in 1988, Dr. Smith organized the “Genes and Machines” conference series in bioinformatics. As director of the Boston University BioMolecular Engineering Research Center, he directed the research of over twenty Post doctoral and graduate students. That research focused on protein evolution of: the WD-repeat family; the Life Guard apoptotic regulatory family; the evolutionary of the Drosophila clade, and the origin and evolutionary of the genetic translation system. He is a follow of the American Association for the Advancement of Science (AAAS), and a fellow of the ISCB. He has 200 plus reviewed scientific publications. In 2011 Dr. Smith was elected Emeritus Professor of BioMedical Engineering at Boston University. Dr. Smith is an avid skier, ice climber, sailor, hockey coach and family man. He is also the co-founder of a gene engineering company, Modular Genetics.

Javier Ortega-Garcia received the M.Sc. degree in electrical engineering (Ingeniero de Telecomunicacion), in 1989; and the Ph.D. degree "cum laude" also in electrical engineering (Doctor Ingeniero de Telecomunicacion), in 1996, both from Universidad Politecnica de Madrid, Spain. Dr. Ortega-Garcia is founder and co-director of the Biometric Recognition Group - ATVS. He is currently a Full Professor at the Escuela Politecnica Superior, Universidad Autonoma de Madrid, where he teaches Digital Signal Processing and Speech Processing courses. He also holds a Masters Degree course in Biometrics. His research interests are focused on biometrics signal processing: on-line signature verification, speaker recognition, web-based biometrics, data fusion and multibiometrics. He has published over 150 international contributions, including book chapters, refereed journal and conference papers. He chaired "Odyssey-04, The Speaker Recognition Workshop", "ICB-09, the 3rd IAPR International Conference on Biometrics" and "ICB-2013, the 6th IAPR International Conference on Biometrics".

James H. Adair is a Professor of Materials Science and Engineering, Bioengineering and Pharmacology at The Pennsylvania State University. His research and teaching interests most recently include biological-nanoscale composite particulates for nanomedical applications, based on colloid and interfacial chemistry, and material chemistry. Dr. Adair received his B.S. in Chemistry (1975) and M.S. (1979) and Ph.D. (1981) in Materials Science and Engineering, all from the University of Florida. From 1981-1982, he was a Fulbright Post-Doctoral Fellow at the University of Western Australia at the Royal Perth Hospital where he studied the biophysical chemistry origin of pathological biomineralization. From 1982 to 1997, Dr. Adair held a variety of professional positions including principal research scientist at Battelle Memorial Institute, research associate at the Materials Research Lab at Penn State, and associate professor at the University of Florida. He has been at Penn State as a Professor of Materials Science and Engineering, Biomedical Engineering, and Pharmacology since 1998. In 2005, he co-founded Pendrea Pharmaceutical, Inc. originally as Keystone Nano, Inc.) and currently serves on the Board of Directors and chief science officer. Dr. Adair is the author/co-author of about 300 publications including over 260 papers, more than 28 US and foreign patents and co-editor of 12 books including the Handbook of Characterization Techniques for the Solid-Solution Interface. Dr. Adair is a Fellow of the American Ceramic Society and the World Academy of Ceramics. He has served in multiple capacities in the American Ceramic Society at the local and national levels. In 2017, he was one of six Faculty Scholar Medal awardees and named as the 2018 Inventor of the Year in the Penn State University System. In 2020, Dr. Adair received the the Frontiers of Science and Society - Rustum Roy Lecture Award at the Annual Meeting of the American Ceramic Society.

Yiannis Koumpouros (BSc, MSc, MBA, PhD) is Ass. Professor in the University of West Attica, Department of Public and Community Health. Specialized in healthinformatics, e-health, m-health, telemedicine, assistivetechnologies, rehabilitation, userssatisfactionassessment, and strategic management. Expert for the European Commission in the e-healthand m-healthsectors, and evaluator of numerous R&D projects. Responsible for the WHODAS 2.0 scale cultural adaptation for the World Health Organization in Greece. Top-levelmanagerial experience in the private and public healthcaresector (chairman of hospitals, member of the board of directors, business development and strategic management director, etc.). Chairman of several committees in the Ministry of Development. Regular member of the Consultative Technical Council (Ministry of Internal Public Administration and Decentralisation), etc. He has published more than 70 papers in reputed journals and conferences and has been serving as an editorial board member of repute. He has participated in more than 50 R&D funded projects in the field of healthcare and ICTs.

Sotiris Avgousti received his degree in Electrical Engineering from Higher Technical Institute, Cyprus in 1986. He then received an MSc in Data Communications and Computer Networks from Brunel University. He received his PhD in Telerobotics in Health from the University of Orleans in France in 2015. Since 2008 he has been working as a Researcher at the Department of Health Science of Cyprus University of Technology (CUT). For many years, he has been involved in research in the field of Data Communications and specifically in Telemedicine subjects, particularly in Tele-Echography, ehealth, mhealth, and Telerobotics. He has a considerable number of papers in international journals and in International Conferences.

Bruna Corrêa received her degree and master’s degree in Biomedical Engineering from University of Barcelona, Spain, in 2014 and 2015, respectively. In 2020, she finished her doctoral thesis in the Biomedical Engineering Department at Medical Intensive Care Unit (ICU) of Hospital Clínic of Barcelona. Her research interests include the development and implementation of Ambient Intelligence (AmI) environment with the aim of improving the efficiency in processes related to patient safety and quality of care in a clinical practice. The AmI environment is equipped with Internet of Things (IoT) technologies that enable an adaptive and dynamic distribution of clinical information based on the role and location of each professional as well as the clinical health status of patients. In addition, she works in a clinical multidisciplinary team which studies data science solutions to decrease the number of adverse events and risk situations in ICUs. Since 2017 she is member of the Spanish Society of Biomedical Engineering. Since 2020, she is Associate Professor in Faculty of Medicine of University of Barcelona.

Oscar Casanova (Electronic Engineering, MBA and PhD in Biomedical Engineering), is Professor at the Rey Juan Carlos University and Carlos III University of Madrid of the Department of Electronic Technology. Researcher at the Center for Biomedical Technology of the Polytechnic University of Madrid in the area of Nanomedicine, in-vitro and in-vivo experimentation since 2014. His research focuses on anticancer optic and magnetic hyperthermia therapies. He has participated directly in projects of the National Research Plan of Spain, and as well as of the European Union. Currently he also works as a Biomedical Applications Development Engineer at Vanyan Solutions SL in Madrid Spain. He was a professor since 2006 at the Simon Bolivar University in Caracas Venezuela and a researcher in Medical Signs and Images. Professor and researcher in bioengineering and electromedicine at the University of Táchira - Venezuela until 2013.